Enhanced Th2 immune response, certain components of Th2-driven inflammation in cancer, may be associated with the antitumor activity of CD4 Th2 cells and tumor-infiltrating granulocytes, especially regulatory eosinophils [35, 36]. This evidence concerns the gene CD4 and neoplasm.